What is the creatinine level for stage 3 kidney disease?

Stage 3 chronic kidney disease is defined by an eGFR of 30-59 mL/min/1.73m², which corresponds to creatinine levels typically ranging from 1.2-3.0 mg/dL depending on age, sex, and muscle mass.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Stage 3 chronic kidney disease (CKD) represents a critical point in kidney function decline where intervention becomes essential to slow progression and prevent complications. Understanding the creatinine levels associated with this stage can help you recognize when kidney function has significantly decreased and when medical attention is urgently needed.

Creatinine is a waste product produced by muscle metabolism that healthy kidneys filter from the blood. When kidney function declines, creatinine levels rise, making it a key marker for assessing kidney health. However, the relationship between creatinine levels and kidney disease stages is more complex than a simple number, as it depends on factors like age, sex, race, and muscle mass.

Understanding Stage 3 Chronic Kidney Disease

Stage 3 chronic kidney disease is diagnosed when the estimated glomerular filtration rate (eGFR) falls between 30-59 mL/min/1.73m². The eGFR is calculated using serum creatinine levels along with age, sex, and race through established formulas like the CKD-EPI equation. This stage is further divided into two substages:

Creatinine Levels and eGFR Ranges by CKD Stage

Creatinine ranges are approximate and vary based on age, sex, race, and muscle mass. eGFR is the primary diagnostic criterion for CKD staging.
CKD StageeGFR (mL/min/1.73m²)Typical Creatinine Range (mg/dL)Kidney Function
NormalNormal≥900.6-1.2Normal or high
Stage 1Stage 1≥900.6-1.2Normal with kidney damage
Stage 2Stage 260-891.0-1.4Mildly decreased
Stage 3aStage 3a45-591.2-2.0Mild to moderately decreased
Stage 3bStage 3b30-441.8-3.0Moderately to severely decreased
Stage 4Stage 415-292.5-5.0Severely decreased
Stage 5Stage 5<15>5.0Kidney failure

Creatinine ranges are approximate and vary based on age, sex, race, and muscle mass. eGFR is the primary diagnostic criterion for CKD staging.

  • Stage 3a: eGFR 45-59 mL/min/1.73m² (mild to moderate decrease)
  • Stage 3b: eGFR 30-44 mL/min/1.73m² (moderate to severe decrease)

At this stage, kidney function has declined to 30-60% of normal capacity, meaning the kidneys are struggling to filter waste products and maintain proper fluid and electrolyte balance.

Creatinine Levels in Stage 3 Kidney Disease

While eGFR is the primary diagnostic criterion for CKD staging, creatinine levels provide the foundation for this calculation. In stage 3 kidney disease, serum creatinine levels typically range from 1.2 to 3.0 mg/dL, though this can vary significantly based on individual factors.

Factors Affecting Creatinine Levels

Several factors influence creatinine levels beyond kidney function:

  • Muscle mass: Higher muscle mass produces more creatinine
  • Age: Creatinine production decreases with age as muscle mass declines
  • Sex: Men typically have higher creatinine levels than women
  • Race: African Americans generally have higher creatinine levels
  • Diet: High protein intake can temporarily increase creatinine
  • Medications: Some drugs can affect creatinine levels or kidney function

Why eGFR is More Accurate Than Creatinine Alone

Healthcare providers rely on eGFR rather than creatinine alone because it accounts for these individual variations. A creatinine level of 1.5 mg/dL might indicate normal kidney function in a large, muscular man but could suggest significant kidney impairment in a small, elderly woman.

Recognizing Stage 3 CKD Symptoms

Many people with stage 3 CKD experience noticeable symptoms as kidney function declines. Early recognition of these symptoms can prompt timely medical intervention and lifestyle changes to slow disease progression.

Common Symptoms

  • Fatigue and weakness due to anemia and toxin buildup
  • Swelling (edema) in legs, ankles, or around the eyes
  • Changes in urination patterns, including foamy or bloody urine
  • Shortness of breath from fluid retention
  • Loss of appetite and nausea
  • Sleep problems and difficulty concentrating
  • High blood pressure that's difficult to control

Complications to Monitor

Stage 3 CKD increases the risk of several complications that require monitoring and management:

  • Anemia from decreased erythropoietin production
  • Bone disease from mineral and hormone imbalances
  • Cardiovascular disease risk increases significantly
  • Electrolyte imbalances, particularly potassium and phosphorus
  • Metabolic acidosis from impaired acid excretion

Monitoring Kidney Function Through Blood Testing

Regular monitoring of kidney function is essential for people with stage 3 CKD to track disease progression and adjust treatment plans. Blood tests provide crucial information about how well the kidneys are functioning and whether interventions are working.

If you're concerned about your kidney function or have risk factors for kidney disease, comprehensive testing can provide valuable insights into your kidney health and overall metabolic status.

Key Biomarkers for Kidney Function

Several biomarkers help assess kidney function and overall health:

  • Serum creatinine: Primary marker for calculating eGFR
  • Blood urea nitrogen (BUN): Measures another waste product filtered by kidneys
  • Cystatin C: Alternative marker less affected by muscle mass
  • Albumin-to-creatinine ratio: Detects protein in urine, indicating kidney damage
  • Electrolytes: Sodium, potassium, and phosphorus levels
  • Hemoglobin: Screens for anemia common in CKD

Testing Frequency Recommendations

For people with stage 3 CKD, the National Kidney Foundation recommends testing every 3-6 months to monitor disease progression and treatment effectiveness. More frequent testing may be needed if:

  • Starting new medications that affect kidney function
  • Experiencing rapid changes in kidney function
  • Managing complications like anemia or bone disease
  • Preparing for kidney replacement therapy

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Managing Stage 3 Kidney Disease

While stage 3 CKD represents significant kidney function loss, proper management can slow progression and improve quality of life. Treatment focuses on addressing underlying causes, managing complications, and preparing for potential kidney replacement therapy.

Medical Management

Healthcare providers typically recommend several interventions for stage 3 CKD:

  • Blood pressure control with ACE inhibitors or ARBs
  • Diabetes management to maintain HbA1c below 7%
  • Cholesterol management to reduce cardiovascular risk
  • Anemia treatment with iron supplements or erythropoiesis-stimulating agents
  • Bone health support with vitamin D and phosphorus management
  • Medication adjustments to prevent further kidney damage

Lifestyle Modifications

Lifestyle changes play a crucial role in managing stage 3 CKD:

  • Following a kidney-friendly diet with controlled protein, sodium, and phosphorus
  • Maintaining a healthy weight to reduce kidney stress
  • Regular exercise as tolerated to improve cardiovascular health
  • Avoiding nephrotoxic substances like NSAIDs and excessive alcohol
  • Staying hydrated but not overhydrating
  • Managing stress through relaxation techniques and support groups

When to Seek Medical Attention

Certain situations require immediate medical attention for people with stage 3 CKD. Recognizing these warning signs can prevent serious complications and hospitalizations.

Emergency Symptoms

  • Severe shortness of breath or chest pain
  • Significant swelling that doesn't improve with elevation
  • Persistent nausea and vomiting preventing food intake
  • Confusion or altered mental status
  • Severe fatigue that interferes with daily activities
  • Blood in urine or significant changes in urination

Regular Follow-up Care

People with stage 3 CKD should maintain regular follow-up with their healthcare team, including nephrologists, primary care physicians, and other specialists as needed. This team approach ensures comprehensive care and early intervention for complications.

Taking Control of Your Kidney Health

Understanding your creatinine levels and eGFR is just the beginning of managing stage 3 kidney disease. Regular monitoring, lifestyle modifications, and working closely with your healthcare team can significantly impact disease progression and quality of life.

If you have existing blood test results and want to understand what they mean for your kidney health, consider uploading them for a comprehensive analysis. SiPhox Health's free upload service can help translate your lab results into clear, actionable insights about your kidney function and overall health status.

Remember that stage 3 CKD is manageable with proper care and attention. By staying informed about your kidney function, following your treatment plan, and making healthy lifestyle choices, you can work toward slowing disease progression and maintaining the best possible quality of life.

References

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements. 2013;3(1):1-150.[DOI]
  2. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Annals of Internal Medicine. 2009;150(9):604-612.[PubMed][DOI]
  3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. American Journal of Kidney Diseases. 2002;39(2 Suppl 1):S1-266.[PubMed]
  4. Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. American Journal of Kidney Diseases. 2014;63(5):713-735.[PubMed][DOI]
  5. Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2021. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2021.[Link]
  6. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. The Lancet. 2017;389(10075):1238-1252.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my creatinine at home?

You can test your creatinine at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes creatinine testing along with eGFR calculation, providing lab-quality results from the comfort of your home.

What creatinine level indicates stage 3 kidney disease?

Stage 3 kidney disease is diagnosed by eGFR (30-59 mL/min/1.73m²) rather than creatinine alone. However, creatinine levels typically range from 1.2-3.0 mg/dL in stage 3, varying based on age, sex, muscle mass, and race.

How often should I test my kidney function with stage 3 CKD?

People with stage 3 CKD should test kidney function every 3-6 months to monitor disease progression. Your healthcare provider may recommend more frequent testing if you're starting new medications or experiencing rapid changes.

Can stage 3 kidney disease be reversed?

While stage 3 CKD cannot typically be reversed, proper management can significantly slow progression and prevent complications. Early intervention with blood pressure control, diabetes management, and lifestyle changes is crucial.

What symptoms should I watch for with stage 3 kidney disease?

Common symptoms include fatigue, swelling in legs or ankles, changes in urination, shortness of breath, loss of appetite, and difficulty controlling blood pressure. Seek immediate medical attention for severe symptoms like chest pain or confusion.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details